BRAF V600E Maintains Proliferation, Transformation, and Tumorigenicity of BRAF-Mutant Papillary Thyroid Cancer CellsDingxie Liu, Mingzhao Xing|The Journal of Clinical Endocrinology & Metabolism|2007Cited by 124
Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of RapamycinDingxie Liu, Mingzhao Xing|Cancer Research|2009Cited by 88